{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:14:40Z","timestamp":1775060080261,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Session 2 of the 2024 European Association for Haematopathology\/Society for Hematopathology lymphoma workshop was dedicated to atypical lymphoproliferations in association with germline genetic variants. The first group of cases were lymphoproliferations occurring in the context of primary immunodeficiencies (PID), a heterogeneous group of diseases with increasing incidence and number of different diseases due to better recognition. The workshop contained a spectrum of different PIDs and associated lymphoproliferations with autoimmune lymphoproliferative syndrome, activated phosphoinositide 3-kinase delta syndrome, ataxia-telangiectasia and common variable immune deficiency being the most common. Both children and adults were affected, and the diagnosis of an underlying PID often required a high index of suspicion and correlation with clinical presentation and immunological\/ infectious workup. Recognition of a PID allows specific treatment and can influence the interpretation of lymphoproliferations occurring in this context. The spectrum of lymphoproliferations ranged from reactive to overt lymphoma, both EBV-positive and -negative. In a subset of cases, it was very difficult or impossible to establish the boundary between reactive and neoplastic in the context of a PID. The second group represented a heterogeneous group of lymphoproliferations in the context of mutations in germline haematopoietic malignancy risk genes, without associated immunodeficiency. It was often difficult to determine if the genetic defect and the lymphoproliferation were causally related or coincidental, especially if the patient was also treated for non-lymphoid conditions. This is a rapidly evolving field in which future studies are expected to shed more light on the relationship between germline mutations and lymphoid malignancy.<\/jats:p>","DOI":"10.1007\/s00428-025-04189-0","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T05:12:22Z","timestamp":1754025142000},"page":"275-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atypical lymphoproliferations associated with germline genetic variants: a report of the 2024 EA4HP\/SH lymphoma workshop"],"prefix":"10.1007","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-6254","authenticated-orcid":false,"given":"Michiel","family":"van den Brand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3118-8824","authenticated-orcid":false,"given":"L\u00edvia","family":"R\u00e1s\u00f3-Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-3627","authenticated-orcid":false,"given":"Gorana","family":"Gasljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-3675","authenticated-orcid":false,"given":"Olga","family":"Balague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-7512","authenticated-orcid":false,"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-325X","authenticated-orcid":false,"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5043-6043","authenticated-orcid":false,"given":"Ioannis","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-8085","authenticated-orcid":false,"given":"James R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5250-3159","authenticated-orcid":false,"given":"Stefan","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5365","authenticated-orcid":false,"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-1340","authenticated-orcid":false,"given":"Birgitta","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7688-1439","authenticated-orcid":false,"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"7","key":"4189_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM et al (2022) Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 42(7):1473\u20131507","journal-title":"J Clin Immunol"},{"key":"4189_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852937","volume":"13","author":"S Chandra","year":"2022","unstructured":"Chandra S, Kalashnikova T, Wright NAM, Davila Saldana BJ (2022) Primary immunodeficiencies and hematologic malignancies: a diagnostic approach. Front Immunol 13:852937","journal-title":"Front Immunol"},{"key":"4189_CR3","doi-asserted-by":"crossref","unstructured":"Thalhammer J, Kindle G, Nieters A, Rusch S, Seppanen MRJ, Fischer A et al (2021) Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol 148(5):1332\u20131341","DOI":"10.1016\/j.jaci.2021.04.015"},{"key":"4189_CR4","doi-asserted-by":"crossref","unstructured":"Gathmann B, Mahlaoui N, Ceredih, Gerard L, Oksenhendler E, Warnatz K et al (2014) Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 134(1):116\u2013126","DOI":"10.1016\/j.jaci.2013.12.1077"},{"key":"4189_CR5","doi-asserted-by":"publisher","first-page":"1059914","DOI":"10.3389\/fonc.2023.1059914","volume":"13","author":"Y Chu","year":"2023","unstructured":"Chu Y, Liu Y, Fang X, Jiang Y, Ding M, Ge X et al (2023) The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends. Front Oncol 13:1059914","journal-title":"Front Oncol"},{"issue":"2","key":"4189_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ajcp\/aqw215","volume":"147","author":"D Gratzinger","year":"2017","unstructured":"Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR et al (2017) Primary\/congenital immunodeficiency: 2015 SH\/EAHP workshop report-part 5. Am J Clin Pathol 147(2):204\u2013216","journal-title":"Am J Clin Pathol"},{"issue":"18","key":"4189_CR7","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","volume":"118","author":"B Neven","year":"2011","unstructured":"Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L et al (2011) A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 118(18):4798\u20134807","journal-title":"Blood"},{"issue":"14","key":"4189_CR8","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","volume":"116","author":"JB Oliveira","year":"2010","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ et al (2010) Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116(14):e35\u201340","journal-title":"Blood"},{"issue":"13","key":"4189_CR9","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","volume":"123","author":"S Price","year":"2014","unstructured":"Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE et al (2014) Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood 123(13):1989\u20131999","journal-title":"Blood"},{"issue":"7","key":"4189_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","volume":"29","author":"I Maric","year":"2005","unstructured":"Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J et al (2005) Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 29(7):903\u2013911","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4189_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/10428190310001593166","volume":"45","author":"S Poppema","year":"2004","unstructured":"Poppema S, Maggio E, van den Berg A (2004) Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations. Leuk Lymphoma 45(3):423\u2013431","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"4189_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V98.1.194","volume":"98","author":"SE Straus","year":"2001","unstructured":"Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, Rosen-Wolff A et al (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98(1):194\u2013200","journal-title":"Blood"},{"issue":"2","key":"4189_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5858\/arpa.2018-0190-RS","volume":"144","author":"DR Matson","year":"2020","unstructured":"Matson DR, Yang DT (2020) Autoimmune lymphoproliferative syndrome: an overview. Arch Pathol Lab Med 144(2):245\u2013251","journal-title":"Arch Pathol Lab Med"},{"key":"4189_CR14","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood"},{"key":"4189_CR15","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4th edn. International Agency for Research on Cancer, Lyon"},{"key":"4189_CR16","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia"},{"issue":"5","key":"4189_CR17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0301-472X(99)00033-8","volume":"27","author":"AM Peters","year":"1999","unstructured":"Peters AM, Kohfink B, Martin H, Griesinger F, Wormann B, Gahr M et al (1999) Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin\u2019s disease. Exp Hematol 27(5):868\u2013874","journal-title":"Exp Hematol"},{"issue":"4","key":"4189_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/PAS.0b013e3181d5ddf8","volume":"34","author":"G Venkataraman","year":"2010","unstructured":"Venkataraman G, McClain KL, Pittaluga S, Rao VK, Jaffe ES (2010) Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol 34(4):589\u2013594","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4189_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/imr.13291","volume":"322","author":"N Romberg","year":"2024","unstructured":"Romberg N, Le Coz C (2024) Common variable immunodeficiency, cross currents, and prevailing winds. Immunol Rev 322(1):233\u2013243","journal-title":"Immunol Rev"},{"issue":"1","key":"4189_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E et al (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111(1):77\u201385","journal-title":"Blood"},{"issue":"12","key":"4189_CR21","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/00000478-199212000-00004","volume":"16","author":"CA Sander","year":"1992","unstructured":"Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES (1992) Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 16(12):1170\u20131182","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4189_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","volume":"33","author":"JN Boursiquot","year":"2013","unstructured":"Boursiquot JN, Gerard L, Malphettes M, Fieschi C, Galicier L, Boutboul D et al (2013) Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 33(1):84\u201395","journal-title":"J Clin Immunol"},{"issue":"6","key":"4189_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10875-014-0052-1","volume":"34","author":"S Unger","year":"2014","unstructured":"Unger S, Seidl M, Schmitt-Graeff A, Bohm J, Schrenk K, Wehr C et al (2014) Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency. J Clin Immunol 34(6):615\u2013626","journal-title":"J Clin Immunol"},{"issue":"7","key":"4189_CR24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119(7):1650\u20131657","journal-title":"Blood"},{"issue":"5","key":"4189_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/ejh.13687","volume":"107","author":"T Smith","year":"2021","unstructured":"Smith T, Cunningham-Rundles C (2021) Lymphoid malignancy in common variable immunodeficiency in a single-center cohort. Eur J Haematol 107(5):503\u2013516","journal-title":"Eur J Haematol"},{"issue":"5","key":"4189_CR26","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10875-011-9565-z","volume":"31","author":"SP da Silva","year":"2011","unstructured":"da Silva SP, Resnick E, Lucas M, Lortan J, Patel S, Cunningham-Rundles C et al (2011) Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol 31(5):784\u2013791","journal-title":"J Clin Immunol"},{"issue":"8","key":"4189_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00277-008-0691-5","volume":"88","author":"MN Polizzotto","year":"2009","unstructured":"Polizzotto MN, McComish JS, Dawson MA, Opat SS, Cole-Sinclair MF (2009) Burkitt lymphoma in the setting of common variable immunodeficiency. Ann Hematol 88(8):819\u2013820","journal-title":"Ann Hematol"},{"key":"4189_CR28","doi-asserted-by":"publisher","first-page":"1208567","DOI":"10.3389\/fimmu.2023.1208567","volume":"14","author":"S Vanselow","year":"2023","unstructured":"Vanselow S, Wahn V, Schuetz C (2023) Activated PI3Kdelta syndrome - reviewing challenges in diagnosis and treatment. Front Immunol 14:1208567","journal-title":"Front Immunol"},{"key":"4189_CR29","doi-asserted-by":"crossref","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N et al (2017) Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study. J Allergy Clin Immunol 139(2):597\u2013606","DOI":"10.1016\/j.jaci.2016.06.021"},{"key":"4189_CR30","doi-asserted-by":"crossref","unstructured":"Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L et al (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study. J Allergy Clin Immunol 138(1):210\u2013218","DOI":"10.1016\/j.jaci.2016.03.022"},{"issue":"1","key":"4189_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10238-023-01259-y","volume":"24","author":"J Hanson","year":"2024","unstructured":"Hanson J, Bonnen PE (2024) Systematic review of mortality and survival rates for APDS. Clin Exp Med 24(1):17","journal-title":"Clin Exp Med"},{"issue":"7","key":"4189_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s10875-014-0083-7","volume":"34","author":"SG Tangye","year":"2014","unstructured":"Tangye SG (2014) XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. J Clin Immunol 34(7):772\u2013779","journal-title":"J Clin Immunol"},{"issue":"1","key":"4189_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","volume":"117","author":"C Booth","year":"2011","unstructured":"Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H et al (2011) X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 117(1):53\u201362","journal-title":"Blood"},{"issue":"5","key":"4189_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10875-020-00790-x","volume":"40","author":"JC Ravell","year":"2020","unstructured":"Ravell JC, Chauvin SD, He T, Lenardo M (2020) An update on XMEN disease. J Clin Immunol 40(5):671\u2013681","journal-title":"J Clin Immunol"},{"issue":"1","key":"4189_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1172\/JCI131116","volume":"130","author":"JC Ravell","year":"2020","unstructured":"Ravell JC, Matsuda-Lennikov M, Chauvin SD, Zou J, Biancalana M, Deeb SJ et al (2020) Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest 130(1):507\u2013522","journal-title":"J Clin Invest"},{"issue":"2","key":"4189_CR36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s10875-019-00604-9","volume":"39","author":"X Dong","year":"2019","unstructured":"Dong X, Liu L, Wang Y, Yang X, Wang W, Lin L et al (2019) Novel heterogeneous mutation of TNFAIP3 in a Chinese patient with Behcet-like phenotype and persistent EBV viremia. J Clin Immunol 39(2):188\u2013194","journal-title":"J Clin Immunol"},{"issue":"7","key":"4189_CR37","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10875-020-00823-5","volume":"40","author":"MD Gans","year":"2020","unstructured":"Gans MD, Wang H, Moura NS, Aksentijevich I, Rubinstein A (2020) A20 Haploinsufficiency presenting with a combined immunodeficiency. J Clin Immunol 40(7):1041\u20131044","journal-title":"J Clin Immunol"},{"issue":"1","key":"4189_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y et al (2016) Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet 48(1):67\u201373","journal-title":"Nat Genet"},{"key":"4189_CR39","doi-asserted-by":"crossref","unstructured":"Elhani I, Riller Q, Boursier G, Hentgen V, Rieux-Laucat F, Georgin-Lavialle S (2014) A20 haploinsufficiency: a systematic review of 177 cases. J Invest Dermatol 144(6):1282\u20131294","DOI":"10.1016\/j.jid.2023.12.007"},{"issue":"7788","key":"4189_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","volume":"577","author":"N Lalaoui","year":"2020","unstructured":"Lalaoui N, Boyden SE, Oda H, Wood GM, Stone DL, Chau D et al (2020) Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature 577(7788):103\u2013108","journal-title":"Nature"},{"issue":"2","key":"4189_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10689-021-00248-y","volume":"21","author":"F Lesueur","year":"2022","unstructured":"Lesueur F, Easton DF, Renault AL, Tavtigian SV, Bernstein JL, Kote-Jarai Z et al (2022) First international workshop of the ATM and cancer risk group (4\u20135 December 2019). Fam Cancer 21(2):211\u2013227","journal-title":"Fam Cancer"},{"key":"4189_CR42","doi-asserted-by":"crossref","unstructured":"Micol R, Ben Slama L, Suarez F, Le Mignot L, Beaute J, Mahlaoui N et al (2011) Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol 128(2):382\u2013389","DOI":"10.1016\/j.jaci.2011.03.052"},{"issue":"4","key":"4189_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13951","volume":"34","author":"RC Vieira","year":"2023","unstructured":"Vieira RC, Pinho LG, Westerberg LS (2023) Understanding immunoactinopathies: a decade of research on WAS gene defects. Pediatr Allergy Immunol 34(4):e13951","journal-title":"Pediatr Allergy Immunol"},{"issue":"24","key":"4189_CR44","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood.2023021411","volume":"143","author":"TC Vallee","year":"2024","unstructured":"Vallee TC, Glasmacher JS, Buchner H, Arkwright PD, Behrends U, Bondarenko A et al (2024) Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival. Blood 143(24):2504\u20132516","journal-title":"Blood"},{"issue":"1","key":"4189_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2350\/10-01-0787-CR.1","volume":"14","author":"S Du","year":"2011","unstructured":"Du S, Scuderi R, Malicki DM, Willert J, Bastian J, Weidner N (2011) Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol 14(1):64\u201370","journal-title":"Pediatr Dev Pathol"},{"issue":"22","key":"4189_CR46","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1182\/blood-2018-07-863431","volume":"132","author":"I Brigida","year":"2018","unstructured":"Brigida I, Zoccolillo M, Cicalese MP, Pfajfer L, Barzaghi F, Scala S et al (2018) T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency. Blood 132(22):2362\u20132374","journal-title":"Blood"},{"issue":"20","key":"4189_CR47","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1093\/hmg\/ddab141","volume":"30","author":"S Feurstein","year":"2021","unstructured":"Feurstein S, Drazer M, Godley LA (2021) Germline predisposition to hematopoietic malignancies. Hum Mol Genet 30(20):R225\u2013R235","journal-title":"Hum Mol Genet"},{"issue":"3","key":"4189_CR48","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_432218","volume":"44","author":"LA Godley","year":"2024","unstructured":"Godley LA, DiNardo CD, Bolton K (2024) Germline predisposition in hematologic malignancies: testing, management, and implications. Am Soc Clin Oncol Educ Book 44(3):e432218","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"24","key":"4189_CR49","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood.2022015790","volume":"140","author":"S Feurstein","year":"2022","unstructured":"Feurstein S, Trottier AM, Estrada-Merly N, Pozsgai M, McNeely K, Drazer MW et al (2022) Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages. Blood 140(24):2533\u20132548","journal-title":"Blood"},{"issue":"3","key":"4189_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2020.101197","volume":"33","author":"SS Sahoo","year":"2020","unstructured":"Sahoo SS, Kozyra EJ, Wlodarski MW (2020) Germline predisposition in myeloid neoplasms: unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes. Best Pract Res Clin Haematol 33(3):101197","journal-title":"Best Pract Res Clin Haematol"},{"key":"4189_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108386","volume":"788","author":"B Szmyd","year":"2021","unstructured":"Szmyd B, Mlynarski W, Pastorczak A (2021) Genetic predisposition to lymphomas: overview of rare syndromes and inherited familial variants. Mutat Res Rev Mutat Res 788:108386","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"2","key":"4189_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.15","volume":"7","author":"OC Leeksma","year":"2017","unstructured":"Leeksma OC, de Miranda NF, Veelken H (2017) Germline mutations predisposing to diffuse large B-cell lymphoma. Blood Cancer J 7(2):e532","journal-title":"Blood Cancer J"},{"issue":"9","key":"4189_CR53","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1182\/blood.2020005844","volume":"136","author":"J Stremenova Spegarova","year":"2020","unstructured":"Stremenova Spegarova J, Lawless D, Mohamad SMB, Engelhardt KR, Doody G, Shrimpton J et al (2020) Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. Blood 136(9):1055\u20131066","journal-title":"Blood"},{"issue":"14","key":"4189_CR54","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood.2023020209","volume":"142","author":"S Cheloor Kovilakam","year":"2023","unstructured":"Cheloor Kovilakam S, Gu M, Dunn WG, Marando L, Barcena C, Nik-Zainal S et al (2023) Prevalence and significance of DDX41 gene variants in the general population. Blood 142(14):1185\u20131192","journal-title":"Blood"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04189-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04189-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04189-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:52:45Z","timestamp":1757328765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04189-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4189"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04189-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}